Study: Jevtana combined with Novantrone reduced death risk in prostate cancer patients
BRIDGEWATER, N.J. Data published in the latest issue of medical journal The Lancet showed that a recently approved drug reduced the risk of death in men with a certain form of prostate cancer by more than a quarter.
French drug maker Sanofi-Aventis said results of the phase-3 “TROPIC” trial indicated that Jevtana (cabazitaxel) combined with prednisone or Merck KGaA’s Novantrone (mitoxantrone) reduced by 30% the risk of death in men with advanced castration-resistant prostate cancer whose disease had progressed after receiving Sanofi’s Taxotere (docetaxel).
“Jevtana is the first approved therapy to fill a critical gap among patients with the most advanced stage of prostate cancer and is the first therapeutic option for those patients shown to prolong survival,” said Oliver Sartor, Tulane Medical School professor and chief investigator for the trial in North America.
Navarro Discount Pharmacies inks deal with Sona
MIAMI Navarro Discount Pharmacies, which operates 28 stores in Miami, has partnered with Sona to provide point-of-sale reporting to all suppliers.
The program will be presented to vendors and suppliers at the Vendor Summit on Oct. 8 hosted by Navarro.
"As a Hispanic-centric retailer, we are committed to understanding our customers and their buying needs within every market we serve; in turn, our partnership with Sona will give our suppliers the tools needed to unlock the potential of this underserved market. We want our vendors to know and understand ‘Hispanic’ at the same level we do," stated Jose Alvarez, VP merchandising.
Sona provides a Web-based dashboard-driven data management solution.
Suppliers will have the ability to look into each category and understand what the key sales drivers are for the category. Custom product hierarchies and store clusters will enable suppliers to view the data in ways that are designed to maximize insights and drive sales. Suppliers also will have the opportunity to review how their products influence the shopper’s market basket.
Bravado, The Bridge Direct to create Justin Bieber dolls
NEW YORK A world’s leading global music merchandising company and a global children’s consumer products sourcing and supply chain management company will team up to create an exclusive line of collectible dolls, singing dolls, toys and plush based on pop star Justin Bieber.
The Bridge Direct’s new Justin Bieber toy line will debut holiday 2010 with:
- The JB Style collection figures for a suggested retail price of $17.99;
- Justin Bieber music video collection singing figures for $27.99 that each "sing" a portion of one of Bieber’s most popular hit songs and come with fun accessories;
- In-concert microphones ($14.99) that play two of Bieber’s hit songs with cool sound effects; and
- The cuddly and collectible Signature Plush ($7.99).
"We’re thrilled to be working with Bravado to create authentic products that Justin’s millions of fans will surely love," said Jay Foreman, president and CEO of The Bridge. "My experience with celebrity-themed toys based on hugely popular musical artists like the Spice Girls, Britney Spears and Disney’s Hannah Montana has given me the ability to bring these must-have products to market for fans just in time for the holiday gift-giving season."